510(k) Report

FDA applicant

Qingdao Hightop Biotech Co., Ltd.

Qingdao, CN3 decisions2019–20240 recalls

FDA records 3 decisions for Qingdao Hightop Biotech Co., Ltd. (Qingdao, CN) from 2019 to 2024: 3 510(k) clearances. Most are in product codes NFT (Test, Amphetamine, Over The Counter) and NGL (Test, Opiates, Over The Counter). Since 2016 its 510(k)s took a median of 40 days from receipt to decision, against 50 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Qingdao Hightop Biotech Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2019: 12022: 12024: 1
2019high 1 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2019.

FIG. 1 — Qingdao Hightop Biotech Co., Ltd. by year, 2019–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Qingdao Hightop Biotech Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report